1. Understand the rationale for using immune checkpoint blockade as a tool for preventing progression to oral cancer.
2. Appreciate the evolving impact of plasma HPV ctDNA on diagnosis, surveillance, and as a potential biomarker across the HPV cancer spectrum
3. Understand how immune effector cell therapies are being applied to solid tumors (not just hematologic malignancies)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation